Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up

BMC Public Health
Angel Vila-CórcolesEVAN Study Group

Abstract

The systematic vaccination with 23-valent polysaccharide pneumococcal vaccine (PPV) was introduced as a strategic objective of health for all the people over 65 in Catalonia in 1999. We analysed the evolution of the pneumococcal vaccination rates from 2000 to 2003. We conducted a retrospective population-based study including all the individuals 65 years or older assigned to 8 Primary Care Centres (PCCs) in Tarragona (Catalonia, Spain), who figured in the administrative population databases on 31 December 2003 (n = 10,410 persons). We assessed whether every person had received PPV during the last four years (2000 to 2003) or whether they had received it before January 2000. Data sources were the computerised clinical records of the 8 participating PCCs, which included adult vaccination registries and diagnoses coded of International Classification of Diseases 9th The overall vaccination uptake increased to 38.6% at the end of 2000. Global accumulated coverages increased more slowly the following years: 44.4% in 2001, 50.9% in 2002, and 53.1% at the end of 2003. Vaccine uptake varied significantly according to age (46.7% in people 65-74 years-old, 60.9% in people 75 years or more; p < 0.001) and number of diseases or risk factor...Continue Reading

References

Feb 22, 2001·Medicina clínica·P Barona Zamora
Oct 30, 2003·The Cochrane Database of Systematic Reviews·K DearD Tatham
Feb 28, 2004·Atencion primaria·A Vila CórcolesUNKNOWN Grupo de Estudio EVAN-65
Mar 17, 2004·Current Opinion in Infectious Diseases·Mark Loeb
Apr 7, 2004·The European Respiratory Journal·B ChristensonA Ortqvist
May 27, 2004·Journal of the American Geriatrics Society·Nicholas A DanielsEliseo J Pérez-Stable

❮ Previous
Next ❯

Citations

Aug 11, 2010·Epidemiology and Infection·X SintesUNKNOWN Working Group for the Study of Prevention of CAP in the Elderly
Oct 11, 2012·BMC Public Health·Berber KoopmansJoke C Korevaar
Jan 19, 2010·Médecine et maladies infectieuses·K RissoC Pulcini
Jul 28, 2016·Human Vaccines & Immunotherapeutics·Angel Vila-CorcolesFrancisca Ramos
May 24, 2014·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Imma GrauRoman Pallares
Aug 4, 2011·Expert Review of Vaccines·David S FedsonSandrine I Samson
Jul 25, 2019·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Angel Vila-CórcolesMaria Aragón

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.